Prospect

The senator wants the inspector general to probe why the NIH licensed a potentially lucrative cancer drug to an obscure company linked to a former employee.

Today on TAP: Military stresses are compounded by economic divisions.

The discussion about Israel and Gaza continues with writer and activist Layla Al-Sheikh.

Parliaments have mechanisms for resolving the impasse in the House of Representatives. The U.S. does not.

It all goes back to Nixon.

The private equity billionaire is leading a boycott of an Ivy League oligarch factory over a Palestinian literary festival it held last month.

Marwan Barghouti has been in an Israeli prison since 2002.

Today on TAP: Biden, the Fed, and the House

Not only for Israel and Ukraine, but also, indirectly and effectively, against Trump and the Republican clown show.

Having to defend them clearly imperils Israeli security.

A second casino vote in Virginia’s capital city is under way.

The free Direct File program is being tested in 13 states this tax season.

Today on TAP: On the similarities between uniting nihilists and herding cats

U.S. policymakers should listen to Gen. Clausewitz, not Gen. MacArthur.

Many are burned out by attacks on public education. But they struggle to find employers willing to take a chance on someone with only classroom experience.

Don’t mess with the anti-monopoly reformers.

Today on TAP: Biden’s fraught Mideast diplomacy

After Hamas boosted its finances with crypto funding, over 100 members of Congress urged a crackdown on crypto money laundering, including two notoriously pro-crypto representatives.

An obscure company affiliated with a former NIH employee is offered the exclusive license for a government-funded cancer drug.

Today on TAP: And why, after 48 years in the organization, I’m quitting.